Sarepta Therapeutics (BSP:S1RP34) Accounts Payable & Accrued Expense : R$2,269 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Sarepta Therapeutics Accounts Payable & Accrued Expense?

Sarepta Therapeutics's quarterly accounts payable & accrued expense increased from Sep. 2024 (R$1,649 Mil) to Dec. 2024 (R$2,365 Mil) but then declined from Dec. 2024 (R$2,365 Mil) to Mar. 2025 (R$2,269 Mil).

Sarepta Therapeutics's annual accounts payable & accrued expense declined from Dec. 2022 (R$1,994 Mil) to Dec. 2023 (R$1,475 Mil) but then increased from Dec. 2023 (R$1,475 Mil) to Dec. 2024 (R$2,365 Mil).

Sarepta Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sarepta Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Accounts Payable & Accrued Expense Chart

Sarepta Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,086.67

1,345.83

1,993.99

1,475.37

2,365.23

Sarepta Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,222.67	1,632.78	1,649.02	2,365.23	2,269.31

Sarepta Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sarepta Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (BSP:S1RP34) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SRPT:USA SRPT:Mexico 1SRPT:Italy 0L35:UK AB3A:Germany AB3A:Germany

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Sarepta Therapeutics Headlines

No Headlines